“You may’t have that safer supply without having there becoming a source,” he said, incorporating they’re mostly planning to sell to researchers and entrance-line personnel instead of straight to drug consumers.“We're going to Examine how the commercialization of the compound fits in with our organization design at Adastra in order to pla